Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Avricore HealthTSXV:AVCR PB Ratio is 27.50 as of Aug. 12, 2026, which is 411% above its 10-year median of 5.38. The stock has 6 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Avricore Health ranks worse than 95.88% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-12), Avricore Health's share price is C$0.055. Avricore Health's Book Value per Share for the quarter that ended in Mar. 2026 was C$0.00. Hence, Avricore Health's PB Ratio of today is 27.50.
Warning Sign:
Avricore Health Inc stock PB Ratio (=27.5) is close to 10-year high of 27.5.
The historical rank and industry rank for Avricore Health's PB Ratio or its related term are showing as below:
TSXV:AVCR'
s PB Ratio Range Over the Past 10 Years
Min: 1.12 Med: 5.38 Max: 27.5
Current: 27.5
During the past 13 years, Avricore Health's highest PB Ratio was 27.50. The lowest was 1.12. And the median was 5.38.
TSXV:AVCR's PB Ratio is ranked worse than 95.88% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.21
vs TSXV:AVCR: 27.50
During the past 12 months, Avricore Health's average Book Value Per Share Growth Rate was -89.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -41.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Avricore Health was 64.50% per year. The lowest was -55.10% per year. And the median was -13.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Avricore Health PB Ratio Related Terms
Avricore Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Avricore Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Avricore Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avricore Health PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Avricore Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Avricore Health's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Avricore Health (TSXV:AVCR) has a PB Ratio of 27.50 as of Aug. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Avricore Health and its competitors. This is 411% above median its historical median of 5.38. Over the past decade, Avricore Health's PB Ratio has ranged from 1.12 to 27.50. According to the industry distribution chart, Avricore Health ranks #186 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 95.9%.
Is Avricore Health's PB Ratio too high?
Avricore Health's current PB Ratio of 27.50 is 411% above median its 10-year median of 5.38. Over the past 10 years, this metric has ranged from a low of 1.12 to a high of 27.50. The Medical Diagnostics & Research industry median PB Ratio is 2.21. Avricore Health's value of 27.50 is 1144.3% above this industry median. Based on the distribution chart, Avricore Health ranks #186 out of 194 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Avricore Health's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Avricore Health ranks #186 out of 194 companies for PB Ratio. This places Avricore Health in the lower half of its industry. The industry median PB Ratio is 2.21. Avricore Health's value of 27.50 is 1144.3% above this benchmark. Historically, Avricore Health's own PB Ratio has ranged from 1.12 to 27.50 over the past decade. While the company's 10-year median is 5.38 vs. the industry median of 2.21, Avricore Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.21, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avricore Health's current PB Ratio of 27.50 is 1144.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Avricore Health and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avricore Health's current PB Ratio is 27.50, which is 411% above median its own 10-year median of 5.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avricore Health stock overvalued right now?
Based on GuruFocus' analysis, Avricore Health (TSXV:AVCR) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.02, compared to a current price of C$0.06 — trading 175% above its estimated fair value. The current PB Ratio is 27.50, which is 411% above median its 10-year median of 5.38 and 1144.3% above the Medical Diagnostics & Research industry median of 2.21. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Avricore Health (TSXV:AVCR), the current PB Ratio is 27.50 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The company has only one segment, being the HealthTab - Point of Care Business in Canada. The company's revenues are generated from operating leases of the POCT system and the sale of testing panels. Geographically, the company operates in Canada and United Kingdom, it derives maximum revenue Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:AVCR has been successfully added to your 
